🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The research team is conducting a randomized, double-blind, placebo-control...
Status
Not Yet Recruiting
Location
Beijing Tiantan Hopital, Capital Medical University
Start Date
2026-02-01
Trial ID
NCT07341958
Treatments Being Tested
The purpose of this study is to evaluate the antiviral effect, safety, tole...
Status
Completed
Location
Kaiser Permenente Los Angeles Medical Center
Start Date
2023-05-23
Trial ID
NCT05869643
This study will examine the effects of doses of opioid/placebo and doses of...
Status
Recruiting
Location
University of Kentucky
Start Date
2025-04-01
Trial ID
NCT06757140
Treatments Being Tested
This is a Phase 2 study in people with Parkinson's disease who experience m...
Status
Recruiting
Location
University of Arkansas for Medical Sciences (Site #208)
Start Date
2026-02-25
Trial ID
NCT07432958
This is a randomised, placebo-controlled, double-blinded, multi-centre, 2-p...
Status
Terminated
Location
Research Site
Start Date
2021-03-12
Trial ID
NCT04643158
The purpose of the study is to assess the safety and efficacy of JNJ-643045...
Status
Completed
Location
Multiple Locations
Start Date
2016-08-25
Trial ID
NCT02877134
Treatments Being Tested
EFFEKTOR is a vanguard, multicenter, phase 2 randomized, double blinded, pl...
Status
Recruiting
Location
UNC Eastowne Kidney Transplant Clinic
Start Date
2024-04-23
Trial ID
NCT06059664
Treatments Being Tested
This is a single-center, randomized, double-blind, placebo-controlled study...
Status
Not Yet Recruiting
Location
Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
Start Date
2025-08-01
Trial ID
NCT06946511
Treatments Being Tested
This research study is designed to evaluate the safety, tolerability, and e...
Status
Terminated
Location
UCLA Stroke Network
Start Date
2004-09
Trial ID
NCT00272909
Treatments Being Tested
This is a pilot study to investigate the effect of danirixin hydrobromide 3...
Status
Terminated
Location
GSK Investigational Site
Start Date
2017-10-16
Trial ID
NCT03170232
Treatments Being Tested